Stockreport

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]

Tectonic Therapeutic, Inc.  (TECX) 
PDF Received U.S. Investigational New Drug (IND) clearance for lead program, TX45 in July 2024 Completed reverse merger with AVROBIO in June 2024, including concurrent pr [Read more]